Mahmoud Ghannoum Selected Research

Mahmoud Ghannoum Research Topics

Disease

18	Infections 01/2023 - 03/2002
8	Neoplasms (Cancer) 05/2024 - 09/2011
8	Onychomycosis (Tinea Unguium) 01/2024 - 03/2002
4	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 09/2022
4	Mycoses (Diseases, Fungus) 01/2024 - 09/2003
4	Dysbiosis 01/2023 - 01/2019
3	Inflammation (Inflammations) 01/2023 - 01/2023
3	Acquired Immunodeficiency Syndrome (AIDS) 03/2020 - 05/2002
3	Bacteremia 10/2012 - 09/2011
2	Carcinoma (Carcinomatosis) 05/2024 - 01/2023
2	Colitis 03/2024 - 01/2022
2	Carcinogenesis 01/2023 - 01/2021
2	Fever (Fevers) 01/2019 - 12/2007
2	Sepsis (Septicemia) 10/2012 - 09/2011
2	Lymphoma (Lymphomas) 01/2005 - 05/2002
1	Coinfection 03/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Ileitis 01/2023
1	Vulvovaginal Candidiasis 12/2022
1	COVID-19 01/2021
1	Opportunistic Infections (Opportunistic Infection) 03/2020
1	Viremia 03/2020
1	Nausea 01/2019
1	Vomiting 01/2019
1	Multiple Myeloma 01/2019
1	Invasive Candidiasis 01/2017
1	Candidemia 01/2017
1	Wound Infection (Wound Infections) 03/2015
1	Candidiasis (Moniliasis) 08/2013
1	Cutaneous Candidiasis 08/2013
1	Keratitis 02/2013

Drug/Important Bio-Agent (IBA)

6	Terbinafine (Lamisil)FDA LinkGeneric 01/2024 - 03/2002
5	Antifungal AgentsIBA 01/2024 - 09/2003
4	Fluconazole (Zonal)FDA LinkGeneric 12/2022 - 08/2013
4	AzolesIBA 12/2018 - 08/2013
3	Itraconazole (Sporanox)FDA LinkGeneric 01/2024 - 10/2015
2	Dextrans (Dextran)FDA Link 03/2024 - 01/2022
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2024 - 01/2022
2	AntigensIBA 01/2021 - 03/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2015
2	TriterpenesIBA 08/2020 - 01/2017
2	ibrexafungerpIBA 08/2020 - 01/2017
2	amorolfineIBA 09/2016 - 03/2016
2	AcidsIBA 09/2016 - 03/2016
2	naftifine (naftifine hydrochloride)FDA Link 01/2016 - 10/2015
2	Dosage Forms (Dosage Form)IBA 10/2012 - 05/2011
2	Caspofungin (Cancidas)FDA Link 04/2008 - 12/2007
1	4-(4-sulfophenylazo)-2-mercuriphenol (SAMP)IBA 01/2023
1	Methyl-Accepting Chemotaxis ProteinsIBA 01/2023
1	Volatile Fatty AcidsIBA 01/2023
1	Hemagglutinins (Hemagglutinin)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	VaccinesIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	SterolsIBA 12/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2022
1	LanosterolIBA 12/2022
1	EnzymesIBA 12/2022
1	Drinking WaterIBA 01/2022
1	MucinsIBA 01/2022
1	CytokinesIBA 01/2022
1	Tight Junction ProteinsIBA 01/2022
1	dectin 1IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	3,5-diisopropylsalicylic acid (DIPS)IBA 01/2021
1	Local AnestheticsIBA 01/2021
1	indolepropanol phosphate (IPP)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 03/2020
1	Viral RNAIBA 03/2020
1	Interleukin-8 (Interleukin 8)IBA 03/2020
1	Interleukin-6 (Interleukin 6)IBA 03/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 12/2018
1	BoronIBA 01/2018
1	tavaboroleIBA 01/2018
1	efinaconazoleIBA 01/2018
1	Ciclopirox (Loprox)FDA LinkGeneric 01/2018
1	EchinocandinsIBA 12/2015
1	Vancomycin FDA LinkGeneric 03/2015
1	Cephalothin (Cefalotin)FDA Link 03/2015
1	Nafcillin FDA LinkGeneric 03/2015

Therapy/Procedure

12	Therapeutics 01/2023 - 05/2002
5	Drug Therapy (Chemotherapy) 05/2024 - 05/2002
4	Catheters 10/2012 - 12/2009
3	Neoadjuvant Therapy 05/2024 - 09/2022
3	Central Venous Catheters 12/2015 - 09/2011
2	Vascular Access Devices (Arterial Line) 12/2015 - 10/2012
1	Fecal Microbiota Transplantation 01/2022
1	Penile Prosthesis (Penile Implants) 01/2021
1	Traction 01/2021
1	Cell Transplantation 01/2019
1	Transplantation 01/2019
1	Autologous Transplantation 01/2019
1	Treatment Delay 02/2018
1	Contact Lenses 02/2013